Showing results (21-30 of 154) with videos related to
Sort By:
Pageof 16
Biochemistry|March 8, 1994
Fibrin-bound lipoprotein(a) promotes plasminogen binding but inhibits fibrin degradation by plasminJ Liu, P C Harpel, V GurewichCanadian Journal of Microbiology|March 1, 1988
Immunogenetic aspects of host immune responseR D InmanThe Journal of Rheumatology. Supplement|April 1, 1992
The role of infection in chronic arthritisR D InmanThe Journal of Rheumatology|June 1, 1987
Arthritis and enteritis--an interface of protean manifestationsR D InmanThe Journal of Nutrition|April 1, 1996
Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosisP C Harpel, X Zhang, W BorthThe Journal of Biological Chemistry|April 10, 1985
Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin IP C Harpel, T S Chang, E VerderberThe Journal of Cell Biology|June 1, 1991
Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migrationS Kojima, P C Harpel, D B RifkinThe Journal of Biological Chemistry|July 28, 1995
Location of the major epsilon-(gamma-glutamyl)lysyl cross-linking site in transglutaminase-modified human plasminogenE Bendixen, P C Harpel, L Sottrup-JensenProceedings of the National Academy of Sciences of the United States of America|November 1, 1992
Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolismP C Harpel, V T Chang, W BorthBlood|September 1, 1985
Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assayA P Kaplan, B Gruber, P C HarpelPageof 16